Display options
Share it on

J Clin Diagn Res. 2016 Jan;10(1):ZC60-2. doi: 10.7860/JCDR/2016/16091.7121. Epub 2016 Jan 01.

Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients.

Journal of clinical and diagnostic research : JCDR

Raj Kumar Badam, Jyotsna Suram, Dara Balaji Gandhi Babu, Shefali Waghray, Rahul Marshal, Sharath Chandra Bontha, Reddy Lavanya, Sudheer Kanth

Affiliations

  1. Reader, Department of Oral Medicine & Radiology, Panineeya Mahavidhyalaya College of Dental Sciences , Hyderabad, India .
  2. Senior Lecturer, Department of Oral Medicine & Radiology, Shadan Dental College , Hyderabad, India .
  3. Professor and Head of Department, Department of Oral Medicine & Radiology, Panineeya Mahavidhyalaya College of Dental Sciences , Hyderabad, India .
  4. Senior Lecturer, Department of Oral Medicine & Radiology, Panineeya Mahavidhyalaya College of Dental Sciences , Hyderabad, India .
  5. Professor, Department of Oral Medicine & Radiology, Panineeya Mahavidhyalaya College of Dental Sciences , Hyderabad, India .
  6. Reader, Department of Oral & Maxillofacial Pathology, Mamatha Dental College , Khammam, Telangana State, India .

PMID: 26894178 PMCID: PMC4740706 DOI: 10.7860/JCDR/2016/16091.7121

Abstract

INTRODUCTION: Thyroid carcinoma represents less than 1% of all cancers. The first line of treatment for thyroid cancer is partial/total thyroidectomy. High-dose Iodine(131) therapy using Iodine radioisotopes is commonly used in patients with well differentiated thyroid carcinoma after total thyroidectomy. In this process, the non-thyroidal tissues, such as, salivary gland, stomach and breast tissues also take up radioactive iodine. Salivary gland scintigraphy is widely accepted as a sensitive and valid method for evaluation of salivary gland dysfunction after Radioactive Iodine(131) Therapy (RIT).

AIM: To assess and compare the salivary flow rates, relative uptake and ejection fractions in parotid and submandibular glands just before and one month after Iodine(131) therapy.

MATERIALS AND METHODS: The study was conducted on 24 patients diagnosed with well differentiated thyroid carcinoma who underwent partial/total thyroidectomy and were due for radioactive iodine therapy. These patients were divided into two groups based on the lesion based dosimetry (Group A: 60-100Gy; Group B: 100-150Gy). Salivary gland assessment was done by salivary gland scintigraphy before and after RIT.

STATISTICAL ANALYSIS: The data collected was tabulated and statistically analysed using SPSS software version16 using paired t-test and individual sample t-test.

RESULTS: A statistically significant difference in the uptake percent and ejection fraction percent in the parotid and submandibular glands before RIT and one month after RIT was observed in the study.

CONCLUSION: We inferred from the study that there was an overall decrease in uptake percent and ejection fraction percent one month post RIT in both parotid and submandibular glands. Also, a statistically significant difference was noted in the uptake and ejection fraction percent between Group A and Group B concluding the fact that the damage is dose related.

Keywords: Radioisotopes; Radionuclide imaging; Xerostomia

References

  1. J Oral Pathol Med. 1992 Feb;21(2):70-4 - PubMed
  2. Thyroid. 2013 May;23 (5):609-16 - PubMed
  3. J Oral Maxillofac Surg. 1999 Jun;57(6):738-41 - PubMed
  4. J Nucl Med. 2002 Jan;43(1):61-5 - PubMed
  5. Otolaryngol Clin North Am. 1988 Nov;21(4):649-61 - PubMed
  6. Laryngol Rhinol Otol (Stuttg). 1988 Jul;67(7):362-6 - PubMed
  7. J Nucl Med. 2000 Jul;41(7):1198-202 - PubMed
  8. Nucl Med Mol Imaging. 2011 Sep;45(3):161-8 - PubMed
  9. Laryngoscope. 1967 May;77(5):861-75 - PubMed
  10. J Nucl Med. 2001 Jan;42(1):38-43 - PubMed
  11. Endocr Relat Cancer. 2010 Jun 03;17(3):R161-72 - PubMed
  12. J Nucl Med Technol. 2002 Dec;30(4):165-71; quiz 172-3 - PubMed
  13. Clin Nucl Med. 2002 Nov;27(11):767-71 - PubMed

Publication Types